Cognition is shown to play an important role regulating the body's response to stress. Prolonged or extreme stress compromises cognition and its regulation of the immune system via cortisol. Poor cognition and inflammation are linked, and SARS-CoV-2 causes death through a 'cytokine storm', filling the body with inflammatory material. Those who survive severe infection are likely to experience mental illness as a result of high levels of immune cells. In addition, social isolation measures, changing work conditions and public anxiety are causing an overload on existing mental health support services as needs soar.
The market-ready MyCognition app offers a way to effectively build mental resilience using clinically validated cognitive training games. MyCognition also manages and monitors mental health issues in an adaptive manner using an online, remote cognitive assessment with AI to generate personalised treatment plans. The software is accessible through any iOS/Android device and can be used universally; regardless of age, gender or health-state.
The software is NHS-approved, regulated by MHRA and is CE marked as a Class 1 medical device with 85% ORCHA ranking. With over 25,000 existing user data points, the software has been adopted internationally in education and workplace settings.
Rigorous clinical trials and published evidence have established MyCognition for use in clinical settings such as helping manage Cancer, Diabetes, PTSD, Depression and Cognitive Impairment.
MyCognition is poised to merge with the skills of health practitioners and well-being services to benefit the health, prevention and productivity of everyone during this crisis.